Thermo Fisher Scientific Launches Invitrogen™ TaqMan™ Cells-to-CT™ HepatoExpress Kit to Simplify Liver Cell Gene Expression and Help Advance Early-Stage Drug ...
Validated next-generation sequencing soon will become necessary in ensuring the safety and efficacy of cell and gene ...
A profound transformation is taking place in therapeutic discovery, development, and delivery.2026 will be a pivotal year for ...
Honeybees are vital to global food security, yet colony collapse threatens ecosystems and agriculture worldwide.   Discover ...
The transition to AgriGenX ensures full continuity for existing customers and partners. The current portfolio of products, ...
This study presents a comprehensive approach for assessing multiple quality attributes of antibody-oligonucleotide conjugates ...
Factorial Biotechnologies, a leader in next-generation single-cell sequencing solutions, and Honeycomb Biotechnologies, a pioneer in instrument-free single-cell analysis, today announced a strategic ...
Pharma industry experts indicate that strategy in 2026 is shifting to agentic AI, sustainable efficiency, and resilient supply chains to manage tariffs, regulations, and digitalization.
Understanding how a potential drug is metabolised in the liver is a critical first step in early-stage drug development - but ...
Extracellular vesicles (EVs), including exosomes, microvesicles, apoptotic bodies, and many other EV subtypes, have emerged ...
But in the 1990s the virus that causes AIDS turned out to offer a solution. Researchers discovered how to strip away HIV’s destructive genes and repurpose it as a “lentiviral vector”—a tool to deliver ...